BAH
Booz Allen Hamilton
2.2%
0.0%
$79.95
$79.95
Why This Position Exists
BAH's thesis assessment classifies the stock as price-below-value with MEDIUM confidence, driven by a compelling valuation disconnect: the stock trades at ~13.4x achievable FY2026 EPS ($5.95+ at 75% probability, 0.88 agreement) for a company generating $825-900M FCF with a $38B+ backlog and genuine cleared-workforce moat (~32,000 personnel). The 57% decline from peak appears to overweight civil business deterioration (25% of revenue) while undervaluing the growing national security business (75% of revenue). The ensemble's near-consensus on EPS achievement, combined with legitimate but priced-in uncertainty on civil recovery (45%) and FY2027 guidance (52%), supports opening a position at quarter-Kelly sizing.
Trigger: Initial thesis assessment generated 2026-03-20 from completed BAH analysis (6 lenses: Gravy Gauge, Regulatory Reader, Moat Mapper, Consolidation Calibrator, Stress Scanner, Myth Meter). Classification driven by EPS valuation math and FCF profile relative to 57% price decline.
Key Market Signals
Committee Verdict
The Portfolio Analyst's proposal is grounded in sound valuation math — 13.4x achievable EPS for a company with $825-900M FCF and a genuine cleared-workforce moat. The Risk Manager's quarter-Kelly sizing at 2.2% already incorporates a heavy tail risk discount (-0.30 from three escalation markets), producing a minimum-threshold position that inherently limits downside. The Devil's Advocate raised three high-severity concerns — cost-cut multiple compression, funded backlog structural impairment, and correlated DOGE policy risk — all of which are legitimate and transparently acknowledged by the thesis itself. However, these concerns are adequately addressed by the sizing: a 2.2% position means even a 30% drawdown costs only 0.66% of NAV, while the upside from potential re-rating of a $825M FCF business trading at 13x earnings provides asymmetric optionality. The mixed assessment from the Devil's Advocate would warrant a weight reduction on a larger position, but at minimum threshold, further reduction would bring the position below the 2% floor.
Devil's Advocate
mixedThe thesis has genuine quantitative support from the EPS market (75%, high agreement) and the valuation math is arithmetically sound at 13.4x. However, three high-severity concerns warrant attention: (1) cost-cut-driven EPS may warrant a lower multiple than the thesis implies, (2) the funded backlog trend validates structural revenue concerns rather than just cyclical headwinds, and (3) DOGE policy risk is a correlated exogenous factor that could cause multiple thesis-critical markets to fail simultaneously. The quarter-Kelly sizing at 2.2% provides meaningful protection — this is a minimum-size position that limits downside while maintaining optionality. The mixed assessment reflects genuine thesis merit tempered by material structural and political risks that the analysis transparently acknowledges but may underweight.
Notable Dissent
Devil's Advocate raised material concerns about correlated DOGE policy risk — where a single exogenous policy decision could cause funded backlog, civil revenue, and FY2027 guidance markets to all resolve negatively simultaneously. This correlation risk is real and not fully captured by the Kelly model's independent tail risk discounts. The concern is valid but mitigated by the minimum-size position: at 2.2% weight, even total loss of position would not materially impair the portfolio. The structural-vs-cyclical debate on the civil business decline remains genuinely unresolved.
Monitoring Triggers
• Re-evaluate on Q4 FY2026 earnings release (expected late May/early June 2026) — critical for EPS achievement market resolution and FY2027 guidance
• Re-evaluate if funded backlog stabilization market resolves negative (continued YoY decline in Q4) — would escalate structural concern
• Re-evaluate if DOGE announces material expansion of federal consulting spending cuts — exogenous regime risk
• Mandatory review if position return drops below -20%
• Re-evaluate at 60-day thesis staleness threshold (May 19, 2026) if no prior trigger fires
Position Details
Mar 20, 2026
27
price-below-value
MEDIUM
Government/Defense Services
1
Kelly Sizing Breakdown
EDGE
ODDS
KELLY
Trade History
| Date | Action | Shares | Price | Weight | Rationale |
|---|---|---|---|---|---|
| Mar 20, 2026 | OPEN | 27 | $79.95 | 0.0% → 2.2% | Opening minimum-threshold position in BAH based on price-below-value classification (MEDIUM confidence). Stock at 13.4x achievable FY2026 EPS with $825-900M FCF, $38B+ backlog, and cleared workforce moat. Quarter-Kelly sizing at 2.2% reflects heavy tail risk discount from DOGE policy uncertainty and funded backlog decline. Devil's Advocate raised mixed assessment on correlated policy risk, adequately mitigated by minimum position size. |
Full Committee Transcripts (1)
Complete 4-step discourse records — expand each step to see the full reasoning from analyst, risk manager, devil's advocate, and committee chair.